ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0473

The Number of Rheumatoid Arthritis Patients Who Give up Pregnancy Due to the Disease Is Decreasing

Ryo Inoue1, Sakiko Isojima1, Toshihiro Matsui2, Shigeto Tohma3 and Nobuyuki Yajima4, 1Division of Rheumatology, Department of Medicine, Showa University School of Medicine, Shinagawa City, Tokyo, Japan, 2NHO Sagamihara National Hospital, Kanagawa, Japan, 3NHO Tokyo National Hospital, Dallas, TX, 4Showa-Universtiy of Medicine, Tokyo, Japan

Meeting: ACR Convergence 2023

Keywords: pregnancy, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0460–0479) Reproductive Issues in Rheumatic Disorders Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Biologics have been shown not to be a disruption in pregnancy, and the reproductive health care environment surrounding rheumatoid arthritis patients has improved significantly. In this study, we attempted to assess changes in attitudes toward pregnancy among female rheumatoid arthritis patients of childbearing age using a questionnaire.

Methods: A cross-sectional study using the NinJa database conducted at 49 sites in 2020, a database of RA patients in Japan collected from April 1, 2020 to March 31, 2021. We selected women under 50 years of age who answered a questionnaire on changes in the desired number of children due to the presence of rheumatoid arthritis. Of these, we excluded those who answered that they already had the desired number of children or that they did not want to have children. We compared the percentage of patients who reported that the onset of rheumatoid arthritis had reduced their desire for children in the three groups based on the time of onset of the disease (“before 2000,” “2001-2011,” and ” after 2012″). We also evaluated the stratification by age at onset (24 years and younger, 25 to 34 years, and 35 years and older), the reasons why respondents answered that they wanted fewer children.

Results: Of 15553 patients, 468 were selected, of which 188 were excluded, leaving 280 eligible cases. The number of patients who reported that the onset of rheumatoid arthritis reduced the desired number of children was 57% (20/35) for onset before 2000, 47% (63/133) for onset between 2001 and 2011, and 35% (39/112) for onset after 2012. Within each group, when further divided into three groups according to age at onset, especially in the 25-34 age group, the percentage of patients who reported a reduction in the desired number of children decreased with the time of onset.

We analyzed the reasons for the 122 patients who indicated that they wanted to have fewer children, and found that the most common reason was “I am worried about my ability to take care of my children” (40%: 49 patients). The next most common reason was “I am worried about the effects of the medication on my child” (25%: 30 patients).

Conclusion: In this study, the desired pregnancy outcome was particularly improved in the 25-34 age group, who are likely to be thinking about pregnancy and childbirth in the near future, possibly due to improvements in the treatment environment, such as an increase in the number of drugs available during pregnancy and the accumulation of information on pregnancy complicated by rheumatoid arthritis. On the other hand, the reasons behind the decrease in pregnancy desire may include limitations in physical function and financial burden, which will be an issue to be addressed in the future.


Disclosures: R. Inoue: None; S. Isojima: None; T. Matsui: Abbie, 6, Asahikasei Pharma Corp., 5, 6, Astellas, 6, Chugai Pharmaceutical Co, Ltd., 5, 6, Eisai Co., Ltd., 6, Eli Lilly Japan, 6, Ono Pharmaceutical Co., Ltd.,, 6, Pfizer Japan Inc., 6; S. Tohma: AbbVie/Abbott, 5, AsahiKASEI Co., Ltd., 6, Chudai Pharmaceutical Co., Ltd., 5, Mitsubishi Tanabe Pharma Corporation, 5, Pfizer Japan Inc., 6; N. Yajima: None.

To cite this abstract in AMA style:

Inoue R, Isojima S, Matsui T, Tohma S, Yajima N. The Number of Rheumatoid Arthritis Patients Who Give up Pregnancy Due to the Disease Is Decreasing [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/the-number-of-rheumatoid-arthritis-patients-who-give-up-pregnancy-due-to-the-disease-is-decreasing/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-number-of-rheumatoid-arthritis-patients-who-give-up-pregnancy-due-to-the-disease-is-decreasing/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology